L-asparaginase induced antithrombin III deficiency: Evidence against the production of a hypercoagulable state
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 29 (4) , 437-442
- https://doi.org/10.1016/0049-3848(83)90247-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complexBlood, 1982
- L-ASPARAGINASE, ANTITHROMBIN III, AND THROMBOSISThe Lancet, 1980
- ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPYThe Lancet, 1980
- Reduced antithrombin III levels during L-asparaginase therapyMedical and Pediatric Oncology, 1980
- Acute Deficiency of Thyroxine-Binding Globulin during L-Asparaginase TherapyNew England Journal of Medicine, 1979
- The effect of L‐asparaginase on plasma coagulation factors in acute lymphoblastic leukemiaCancer, 1977
- L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological StudiesAnnals of Internal Medicine, 1971
- Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatmentCancer, 1971
- L-AsparaginaseNew England Journal of Medicine, 1969
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966